or bone cancer), yet the cells in the new tumor are also radically different from those in the tumor where the cancer started. And the differences between the two are critical. Dr. Karuna Ganesh ...

In mouse models of prostate cancer, MTX-101 delivered twice a week reduced tumor growth, lung metastases, bone remodeling, and tissue loss induced by the presence of metastatic cancer cells in the ...

ECBML, a European-associated laboratory on cancer and bone metastasis, is a collaboration between INSERM (French National Institute of Health and Medical Research) and the University of Sheffield. Off ...

Zoledronic acid is a potent, new-generation bisphosphonate indicated for the treatment of documented bone metastasis in patients with solid tumors and bone lesions associated with multiple myeloma.

ASTRO released a clinical practice guideline with evidence-based recommendations for palliative radiation therapy for ...

Recommended treatment for men with metastatic prostate cancer could be turned on its ear by a clinical trial spanning five countries and led by Dr. Isaac Kim, professor and department chair of the ...

Intravenous; mCRPC: Metastatic castration-resistant prostate cancer; P: Placebo ... the incidence of skeletal-related events (SREs) in bone metastatic CRPC (mCRPC). Denosumab compared with ...

Researchers have found a way to predict which patients are likely to respond to radium-223, a standard treatment for advanced prostate cancer that has spread to the bones. By using an imaging ...

Metastasis remains the primary challenge to ... The new tumor is still colorectal cancer (not brain, liver, or bone cancer), ...

A retrospective study revealed differences in metastasis patterns and treatment utilization by ethnicity among patients with breast cancer and brain metastasis.